- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 129-143 of
247 results
1021 Exhibit: Gordon et al, A Phase I Trial of Recombinant Human Interleukin 11 Ne...
Document
IPR2018-01714, No. 1021 Exhibit - Gordon et al, A Phase I Trial of Recombinant Human Interleukin 11 Neumega rhIL 11 Growth Factor in Women With Breast Cancer Receiving Chemotherapy, B...
|
|
Cite Document
1055 Exhibit: Declaration of James L Mullins, PhD Part 3 of 5
Document
IPR2018-01714, No. 1055-3 Exhibit - Declaration of James L Mullins, PhD Part 3 of 5 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1036 Exhibit: Rajkumar, SV, et al, Combination therapy with lenalidomide plus dexa...
Document
IPR2018-01714, No. 1036 Exhibit - Rajkumar, SV, et al, Combination therapy with lenalidomide plus dexamethasone RevDex for newly diagnosed myeloma, Blood, 1064050 4053 2005 (P.T.A.B....
|
|
Cite Document
1013 Exhibit: Celgene Corp, Press Release, August 28, 2001
Document
IPR2018-01714, No. 1013 Exhibit - Celgene Corp, Press Release, August 28, 2001 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1014 Exhibit: Celgene Corp, Celgene Corporation Receives Orphan Drug Designat...
Document
IPR2018-01714, No. 1014 Exhibit - Celgene Corp, Celgene Corporation Receives Orphan Drug Designation for RevimidTM For Multiple Myeloma, October 8, 2001 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1020 Exhibit: Gebbia et al, Single agent 2,2 difluorodeoxycytidine in the treatment ...
Document
IPR2018-01714, No. 1020 Exhibit - Gebbia et al, Single agent 2,2 difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma a phase II study, La Clinica Terapeutica, 150111 15 19...
|
|
Cite Document
1007 Exhibit: Durie Stepan, Efficacy of Low Dose Thalidomide in Multiple Myeloma,...
Document
IPR2018-01714, No. 1007 Exhibit - Durie Stepan, Efficacy of Low Dose Thalidomide in Multiple Myeloma, Electronic Journal of Oncology, 11 8 2000 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1010 Exhibit: Corral Kaplan, Immunomodulation by thalidomide and thalidomide an...
Document
IPR2018-01714, No. 1010 Exhibit - Corral Kaplan, Immunomodulation by thalidomide and thalidomide analogues, Ann Rheum Dis, 58 I107 I113 1999 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
2005 Exhibit: Ex 2005 Barker
Document
IPR2018-01714, No. 2005 Exhibit - Ex 2005 Barker (P.T.A.B. Dec. 18, 2018)
|
|
Cite Document
2013 Exhibit: Ex 2013 Remes
Document
IPR2018-01714, No. 2013 Exhibit - Ex 2013 Remes (P.T.A.B. Dec. 18, 2018)
|
|
Cite Document
1003 Exhibit: Expert Declaration of Dr Guido Tricot
Document
IPR2018-01714, No. 1003 Exhibit - Expert Declaration of Dr Guido Tricot (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1022 Exhibit: Celesti et al, The association of cyclophosphamide and dexamethaso...
Document
IPR2018-01714, No. 1022 Exhibit - Celesti et al, The association of cyclophosphamide and dexamethasone in advanced refractory multiple myeloma patients, Haematologica, 823351 353 1997 (...
|
|
Cite Document
1011 Exhibit: Rajkumar Kyle, Thalidomide in the Treatment of Plasma Cell Malignan...
Document
IPR2018-01714, No. 1011 Exhibit - Rajkumar Kyle, Thalidomide in the Treatment of Plasma Cell Malignancies, J of Clinical Oncology, 19163593 3595 Aug 2001 (P.T.A.B. Sep. 12, 2018)
|
|
Cite Document
1008 Exhibit: Muller et al, Amino substituted Thalidomide Analogues Potent Inhibito...
Document
IPR2018-01714, No. 1008 Exhibit - Muller et al, Amino substituted Thalidomide Analogues Potent Inhibitors of TNF ¿¿ Productions, Bioorganic Medicinal Chemistry Letters, 91625 1630 1999 (P.T...
|
|
Cite Document
1009 Exhibit: Corral et al, Differential Cytokine Modulation and T Cell Activation by T...
Document
IPR2018-01714, No. 1009 Exhibit - Corral et al, Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That are Potent Inhibitors of TNF ¿¿, J Imm...
|
|
Cite Document
